This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yu, M.-W. Articles by Chen, C.-J. Search for Related Content PubMed PubMed Citation Articles by Yu, M.-W. Articles by Chen, C.-J.

Elevated Serum Testosterone Levels and Risk of Hepatocellular Carcinoma¹

Comprehensive Cancer Center and Division of Environmental Sciences, School of Public Health, Columbia University, New York, New York 10032 [M-W. Y.], and Institute of Public Health, College of Medicine, National Taiwan University, Taipei 10018, Taiwan [C-J. C.]

Serum samples of 9691 male adults had been collected and frozen for a prospective study of hepatocellular carcinoma in Taiwan. After an average follow-up period of 4.6 years, testosterone levels in the stored serum were measured by radioimmunoassay using commercial kits for 35 cases of newly developed hepatocellular carcinoma, 63 hepatitis B surface antigennegative and 77 hepatitis B surface antigen-positive matched controls. Elevated testosterone levels were found to be associated with an increased risk of hepatocellular carcinoma. The association remained significant after the adjustment for effects of other hepatocellular carcinoma risk factors, including hepatitis B surface antigen carrier status, positivity of serum antibody to hepatitis C virus, cigarette smoking, alcohol drinking, past liver disease history, and dietary habits. The multivariate-adjusted relative risk of hepatocellular carcinoma for men with testosterone levels in the upper tertile was 4.1 (95% confidence interval = 1.3–13.2) compared with those having levels in the middle or lower tertiles (P = 0.016). The results consistent with those observed in animal experiments support the hypothesis that testosterone plays a role in the etiology of human hepatocellular carcinoma.

¹ Supported by the Department of Health, Executive Yuan, Republic of China.

² To whom requests for reprints should be addressed, at Institute of Public Health, National Taiwan University College of Medicine, No. 1 Jen-Ai Road, Section 1, Taipei 10018, Taiwan.

Received 6/29/92. Accepted 12/ 4/92.

This article has been cited by other articles:

				R Sato, C Maesawa, K Fujisawa, K Wada, K Oikawa, Y Takikawa, K Suzuki, H Oikawa, K Ishikawa, and T Masuda Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis Gut, July 1, 2004; 53(7): 1001 - 1009. [Abstract] [Full Text] [PDF]

				Y.-M. Sung, N. L.-S. Tang, P. B.-S. Lai, P. K.-S. Chan, and F. K.-L. Chan Re: Hormonal Markers and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: A Nested Case-Control Study Among Men J Natl Cancer Inst, April 2, 2003; 95(7): 559 - 560. [Full Text] [PDF]

				M.-W. Yu, Y.-C. Yang, S.-Y. Yang, S.-W. Cheng, Y.-F. Liaw, S.-M. Lin, and C.-J. Chen Hormonal Markers and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: a Nested Case-Control Study Among Men J Natl Cancer Inst, November 7, 2001; 93(21): 1644 - 1651. [Abstract] [Full Text] [PDF]

				M.-W. Yu, S.-W. Cheng, M.-W. Lin, S.-Y. Yang, Y.-F. Liaw, H.-C. Chang, T.-J. Hsiao, S.-M. Lin, S.-D. Lee, P.-J. Chen, et al. Androgen-Receptor Gene CAG Repeats, Plasma Testosterone Levels, and Risk of Hepatitis B-Related Hepatocellular Carcinoma J Natl Cancer Inst, December 20, 2000; 92(24): 2023 - 2028. [Abstract] [Full Text] [PDF]

				K. Tanaka, H. Sakai, M. Hashizume, and T. Hirohata Serum Testosterone:Estradiol Ratio and the Development of Hepatocellular Carcinoma among Male Cirrhotic Patients Cancer Res., September 1, 2000; 60(18): 5106 - 5110. [Abstract] [Full Text]